Internal Medicine, Critical Care Medicine · Burlington, VT
NPI
1134132913
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
111 Colchester Ave, Patrick 204
Burlington, VT, 05401
Phone (802) 847-6177
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
755 services
Medicare patients, 2024
376
Average age 73
Drug cost, 2024
$699K
849 prescriptions
Company payments, 2025
$3,176
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Kaminsky was code 99291 (critical care e&m), 131 times for 73 patients. In total David Kaminsky billed 755 services in 34 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 131 | 73 | $158.09 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 103 | 71 | $59.37 | $6,116 |
| 99214 Office E&M - Established | Facility | 102 | 80 | $67.18 | $6,853 |
| 94010 Pulmonary Function Testing | Facility | 93 | 89 | $5.65 | $525 |
| 94729 Pulmonary Function Testing | Facility | 48 | 48 | $6.60 | $317 |
| 94060 Pulmonary Function Testing | Facility | 47 | 47 | $7.34 | $345 |
| 94618 Pulmonary Function Testing | Facility | 30 | 30 | $16.09 | $483 |
| 99204 Office E&M - New | Facility | 29 | 29 | $93.38 | $2,708 |
| 99213 Office E&M - Established | Facility | 25 | 25 | $38.15 | $954 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 23 | $81.24 | $1,950 |
| 94726 Pulmonary Function Testing | Facility | 21 | 21 | $8.96 | $188 |
| 99222 Hospital E&M - Initial | Facility | 21 | 20 | $97.87 | $2,055 |
| 94621 Pulmonary Function Testing | Facility | 13 | 13 | $42.95 | $558 |
| 99215 Office E&M - Established | Facility | 11 | 11 | $108.64 | $1,195 |
By year: 2022 $76K for 1,012 services; 2023 $60K for 818 services; 2024 $50K for 755 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Kaminsky prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 94 prescriptions and refills. In total David Kaminsky wrote 849 Medicare prescriptions that cost $699K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 94 | 115 | 18 | $68K |
| Spiriva Respimat Tiotropium Bromide | 82 | 119 | 14 | $57K |
| Prednisone Generic | 62 | 94 | 35 | $361 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 50 | 62 | 26 | $2,000 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 43 | 63 | 12 | $29K |
| Advair Hfa Fluticasone Propion/Salmeterol | 38 | 73 | 12 | $21K |
| Montelukast Sodium Generic | 37 | 111 | 14 | $647 |
| Nucala Mepolizumab | 35 | 49 | Under 11 | $181K |
| Serevent Diskus Salmeterol Xinafoate | 34 | 78 | Under 11 | $31K |
| Qvar Redihaler Beclomethasone Dipropionate | 30 | 68 | Under 11 | $11K |
| Symbicort Budesonide/Formoterol Fumarate | 25 | 53 | 14 | $9,810 |
| Fluticasone Propionate Generic | 22 | 36 | Under 11 | $485 |
| Azithromycin Generic | 21 | 37 | 14 | $168 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 18 | 28 | Under 11 | $3,944 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 16 | 36 | Under 11 | $3,352 |
Brand drugs: 591 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Kaminsky $3,176 ($3,176 in general payments such as food, travel and fees) from 1 company. The largest payer was Medical Graphics Corporation with $3,176.
| Company | Payments | Amount |
|---|---|---|
| Medical Graphics Corporation | 2 | $3,176 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.